Our Stories

Risk more than doubled when hemoglobin A1C levels increased from 5.0% to 5.7%, a range typically considered normal or healthy A well-established marker of diabetes may signify heightened risk of...

Researchers from Quest Diagnostics presented original research on Alzheimer’s disease (AD), based on Quest’s AD-Detect® suite of blood-based biomarker (BBM) testing, at two leading...

Despite widely available lab tests and curative treatment, hepatitis C virus (HCV) remains one of the most common blood-borne infections in the United States. Researchers from Quest Diagnostics,...

In June, researchers from Quest Diagnostics published findings of a national study in The Journal of Clinical Endocrinology and Metabolism (JCEM), the leading clinical journal of the Endocrine...

Experts from Quest Diagnostics will highlight data from 13 studies on a range of laboratory topics at the 2026 Association for Diagnostics & Laboratory Medicine’s (ADLM) Annual Meeting, July 26-30,